GeneNews, Inc.
Records under this name other than patents GeneNews, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,921,074 | Method and Apparatus for Determining a Probability of Colorectal Cancer in a Subject Formerly held In force · High confidence | In force | High confidence | |
| US 9,241,385 | Current Balancing Circuits for Light-Emitting-Diode-Based Illumination Systems Formerly held In force · High confidence | In force | High confidence | |
| US 11,053,551 | Method and apparatus for determining a probability of colorectal cancer in a subject Formerly held Lapsed on the fee record Ended Jul 6, 2025 · USPTO record | Lapsed on the fee record | Ended Jul 6, 2025 | USPTO record |
| US 8,133,675 | Method of profiling gene expression in a subject having an infectious disease Formerly held Term ended Term ended Jan 7, 2020 · USPTO record | Term ended | Term ended Jan 7, 2020 | USPTO record |
| US 8,067,173 | Method of profiling gene expression in a healthy subject Formerly held Term ended Ended no later than Jan 4, 2020 · USPTO record | Term ended | Ended no later than Jan 4, 2020 | USPTO record |
| US 8,101,358 | Method of profiling gene expression in a subject having disease Formerly held Term ended Term ended Jan 4, 2020 · USPTO record | Term ended | Term ended Jan 4, 2020 | USPTO record |
| US 8,110,358 | Method of profiling gene expression in a subject having prostate cancer Formerly held Term ended Ended no later than Jan 4, 2020 · USPTO record | Term ended | Ended no later than Jan 4, 2020 | USPTO record |
| US 8,114,597 | Method of profiling gene expression in a subject undergoing a treatment Formerly held Term ended Ended no later than Jan 4, 2020 · USPTO record | Term ended | Ended no later than Jan 4, 2020 | USPTO record |
| US 8,133,674 | Method of profiling gene expression in a subject having diabetes Formerly held Term ended Ended no later than Jan 4, 2020 · USPTO record | Term ended | Ended no later than Jan 4, 2020 | USPTO record |
| US 8,148,072 | Method of profiling gene expression in a subject having heart failure Formerly held Term ended Ended no later than Jan 4, 2020 · USPTO record | Term ended | Ended no later than Jan 4, 2020 | USPTO record |